These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25068721)

  • 1. Formulation optimization and in vivo proof-of-concept study of thermosensitive liposomes balanced by phospholipid, elastin-like polypeptide, and cholesterol.
    Park SM; Cha JM; Nam J; Kim MS; Park SJ; Park ES; Lee H; Kim HR
    PLoS One; 2014; 9(7):e103116. PubMed ID: 25068721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size of thermosensitive liposomes influences content release.
    Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH
    J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
    Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof.
    Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U
    Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
    Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
    Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer.
    Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z
    ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
    Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
    J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.
    Boakye CH; Patel K; Singh M
    Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave-Triggered Smart Drug Release from Liposomes Co-encapsulating Doxorubicin and Salt for Local Combined Hyperthermia and Chemotherapy of Cancer.
    Jin Y; Liang X; An Y; Dai Z
    Bioconjug Chem; 2016 Dec; 27(12):2931-2942. PubMed ID: 27998076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In depth study on thermosensitive liposomes: Optimizing formulations for tumor specific therapy and in vitro to in vivo relations.
    Lokerse WJ; Kneepkens EC; ten Hagen TL; Eggermont AM; Grüll H; Koning GA
    Biomaterials; 2016 Mar; 82():138-50. PubMed ID: 26761778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
    Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
    Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid-based thermosensitive liposomes.
    Sadeghi N; Deckers R; Ozbakir B; Akthar S; Kok RJ; Lammers T; Storm G
    Int J Pharm; 2018 Sep; 548(2):778-782. PubMed ID: 29126907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.
    Al Sabbagh C; Tsapis N; Novell A; Calleja-Gonzalez P; Escoffre JM; Bouakaz A; Chacun H; Denis S; Vergnaud J; Gueutin C; Fattal E
    Pharm Res; 2015 May; 32(5):1585-603. PubMed ID: 25416027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.